Roche Holding has one of the most promising treatments for Alzheimer’s in clinical trials. The drug is several years away ...

Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...

Carolyn Kay, medical affairs lead at Roche Diagnostics, said it’s “exciting” that these tests are now available in the U.S., ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

Data from two Alzheimer’s tests being developed by Roche Holding AG showed high accuracy in detecting the disease in patients being tested for the condition. The tests measure biomarkers in the blood ...

There are hopes it will offer reassurance to patients with cognitive decline and help them avoid unnecessary further testing, researchers said.

Cepheid and Roche Diagnostics Tests Provide Rapid and Decentralized Detection Options as Mpox Cases Continue to Rise ...

Qure.ai partners with Roche Diagnostics APAC to develop AI-driven medical imaging technologies for healthcare innovation in ...

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s disease related amyloid pathology with very good accuracy. In the largest ...

The global AI in pathology market is projected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024, at a high CAGR of ...

A survey by Roche Diagnostics of 2,836 women aged 25 to 50 from eight Asia-Pacific countries discovered that 44 per cent of respondents delayed or avoided medical treatment because of familial ...